Anixa Biosciences is a biotechnology company focused on using the body's immune system to diagnose, treat and prevent cancer. The company's subsidiary, Anixa Diagnostics Corporation, develops Cchek?, a platform for non-invasive blood tests for the early detection of cancer. The company's subsidiary, Certainty Therapeutics, Inc., develops immuno-therapy drugs against cancer. The company has focused on the development of a treatment for ovarian cancer. The company is also engaged in limited patent licensing activities in the area of encrypted audio/video conference calling.

Capital Bancorp is a bank holding company. Through its subsidiary, Capital Bank, N.A. (the Bank), the company is principally engaged in the business of investing in commercial, real estate, and credit card loans and accepting deposits in Rockville, Columbia and North Bethesda, MD, Reston, VA, and the District of Columbia. The Bank operates three divisions: Commercial Banking, which provides commercial and industrial, commercial real estate and construction lending solutions; Church Street Mortgage, which originates conventional and government-guaranteed residential mortgage loans; and OpenSky?, which provides credit cards to under-banked populations and those looking to rebuild their credit scores.

Gevo is a low-carbon fuel company focused on the development and commercialization of renewable alternatives to petroleum-based products. In addition to serving the low-carbon fuel markets, the company can also serve markets for the production of chemical intermediate products for solvents, plastics, and building block chemicals using its technologies. The company's operating segments include: Gevo segment, which is responsible for research and development activities related to the future production of isobutanol; and Gevo Development/Agri-Energy segment, which is responsible for the operation of its production facility in Luverne, MN and the production of ethanol, isobutanol and related products.

LivePerson is a cloud computing or software-as-a-service provider of solutions on a hosted basis. The company is organized into two operating segments: Business and Consumer. The Business segment enables brands to utilize the company's LiveEngage's engine to connect with consumers through an integrated suite of mobile and online business messaging technologies. The Consumer segment facilitates online transactions between independent service providers and individual consumers seeking information and knowledge for a fee via mobile and online messaging. The company's products and services include: LiveEngage, Professional Services and Consumer Offering.

Paycom Software is a provider of cloud-based human capital management (HCM) solution delivered as Software-as- a-Service. The company provides functionality and data analytics that businesses need to manage the complete employment lifecycle, from recruitment to retirement. The company's solution requires virtually no customization and is based on a core system of record maintained in a single database for various HCM functions, including talent acquisition, time and labor management, payroll, talent management and human resources management applications. The company's solution was developed in-house and is based on a single platform, there is no need to integrate, update or access various databases.

Peoples Financial Services is a bank holding company. Through its subsidiary, the company provides a range of financial services. The company provides a range of retail and commercial lending products to consumers and small- and medium-sized businesses in its market areas. The company's retail lending products include the following types of loans, among others: residential real estate; automobiles; manufactured housing; personal and home equity. The company's commercial lending products include the following types of loans, among others: commercial real estate; working capital; equipment and other commercial needs; construction; Small Business Administration; and agricultural and mineral rights.

USANA Health Sciences develops and manufactures nutritional and personal care products. The company's principal product lines include: USANA? Nutritionals Essentials/CellSentials?, which inclides vitamin and mineral supplements that provide body nutrition for every age group beginning with children 13 months of age; Optimizers, which consists of targeted supplements designed to meet individual health and nutritional needs, such as cardiovascular health, skeletal/structural health, and digestive health; and Foods, which includes low-glycemic meal replacement shakes, snack bars, and other related products that provide macro-nutrition (carbohydrates, proteins, and fats) in various formats.

Vaccinex is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. The company is engaged in the field of semaphorin 4D (SEMA4D) biology, targeting SEMA4D as a potential treatment for cancer, neurodegenerative diseases, or autoimmune disorders. The company is utilizing its SEMA4D antibody platform to develop its primary product candidate, pepinemab (VX15/2503), an antibody that utilizes mechanisms of action. The company is focused on the development of pepinemab for the treatment of non-small cell lung cancer, Huntington's disease, and Alzheimer's disease.